phenoxybenzamine has been researched along with Anemia, Hemolytic in 1 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McKay, DG | 1 |
| Whitaker, AN | 1 |
1 other study available for phenoxybenzamine and Anemia, Hemolytic
| Article | Year |
|---|---|
Studies of catecholamine shock. II. An experimental model of microangiopathic hemolysis.
Topics: Aminocaproates; Anemia, Hemolytic; Animals; Blood Coagulation Disorders; Capillaries; Epinephrine; E | 1969 |